Competing risks and the clinical community: irrelevance or ignorance?
نویسندگان
چکیده
منابع مشابه
Competing risks and the clinical community: irrelevance or ignorance?
Life expectancy has dramatically increased in industrialized nations over the last 200 hundred years. The aging of populations carries over to clinical research and leads to an increasing representation of elderly and multimorbid individuals in study populations. Clinical research in these populations is complicated by the fact that individuals are likely to experience several potential disease...
متن کاملParametric Competing Risks Models in Clinical Trials
Some fully general parametric competing risks models, which allow the underlying (possibly dependent) lifetimes to be modeled as a function of an arbitrary number of covariables, are formulated, and their resulting likelihood function is derived. Under carefully stated regularity conditions, large sample tests of hypotheses concerning the model parameters are obtained for the single point trunc...
متن کاملCompeting risks.
Consider a unit which can experience any one of k competing failure types, and suppose that for each unit we observe the time to failure, T , and the type of failure, C ∈ {1, 2, . . . , k}. The case of observing the pair (T, C) is termed “competing risks” in the statistical literature. After considering some examples we review basic notation and theory of competing risks. In particular we consi...
متن کاملParametric Estimation in a Recurrent Competing Risks Model
A resource-efficient approach to making inferences about the distributional properties of the failure times in a competing risks setting is presented. Efficiency is gained by observing recurrences of the compet- ing risks over a random monitoring period. The resulting model is called the recurrent competing risks model (RCRM) and is coupled with two repair strategies whenever the system fails. ...
متن کاملCompeting risks and multistate models.
Complex clinical endpoints are present in studies in cancer. Especially in studies on hematopoietic stem-cell transplantation (HSCT), various risks exist after HSCT. Patients can experience acute and chronic graft versus host disease (GVHD) or need to undergo immunosuppressive therapy (IST), a relapse can occur, or patients can die after relapse or without former relapse (nonrelapse mortality, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Statistics in Medicine
سال: 2011
ISSN: 0277-6715,1097-0258
DOI: 10.1002/sim.4384